publication date: Dec. 18, 2010

In this issue: 

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

FDA Tightens Conflict of Interest Rules For Advisors.

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

ASCO Study Predicts Shortage of Oncologists.

Download (PDF 761KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.